Drug intelligence / Profile preview

platelet-derived growth factor AB

Development stage
Preclinical
Modality
Hormones & Growth Factors → Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intravitreal, Local Application, Systemic Infusion
01

Overview

Platelet-derived growth factor AB (PDGF-AB) is a dimeric glycoprotein composed of disulfide-bonded A and B polypeptide chains. It functions as a potent growth factor, regulating diverse cellular processes including cell growth, division, proliferation, differentiation, migration, and survival. PDGF-AB exerts its biological effects by binding to and activating specific receptor tyrosine kinases, namely the Platelet-derived growth factor receptor alpha (PDGFRα) and Platelet-derived growth factor receptor beta (PDGFRβ). This activation initiates signal transduction pathways that are crucial for various physiological roles, such as embryonic development, wound healing, angiogenesis (blood vessel formation), and general tissue repair. It is particularly known to promote neuronal survival and recruit glial cells, and acts as a mitogen for mesenchymal cells like fibroblasts, glial cells, and vascular smooth muscle cells.

Other names
Platelet-derived growth factor-AB
02

Targets

PDGFRA (Platelet-derived growth factor receptor alpha)PDGFRB (Platelet-derived growth factor receptor beta)

Beyond the preview

Go deeper on platelet-derived growth factor AB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet-derived growth factor AB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call